Literature DB >> 29109861

Association of smoking with prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals.

Chikara Ueyama1, Hideki Horibe1, Yuichiro Yamase1, Tetsuo Fujimaki2, Mitsutoshi Oguri3, Kimihiko Kato4, Yoshiji Yamada5,6.   

Abstract

Smoking is a significant risk factor for cardiovascular diseases (CVDs). Given that certain common pathologies, including hypertension, dyslipidemia and type 2 diabetes mellitus, are major risk factors for CVDs, the association of smoking with CVDs may be attributable, at least in part, to its effects on common diseases. The aim of the present study was to determine the association of smoking with the prevalence of common diseases and metabolic abnormalities in community-dwelling Japanese individuals. The study included 5,959 subjects (1,302 current smokers, 1,418 past smokers and 3,239 nonsmokers) recruited to the Inabe Health and Longevity Study, a longitudinal genetic epidemiological study of atherosclerotic, cardiovascular and metabolic diseases. Various metabolic parameters and prevalence of common diseases were compared between smokers and nonsmokers using multivariable regression or logistic regression analysis with adjustments for age. Analysis indicated significantly higher serum concentrations of triglycerides and lower concentrations of high-density lipoprotein (HDL)-cholesterol in current smokers compared with nonsmokers in men and women. Serum concentrations of creatinine and systolic blood pressure were significantly lower and estimated glomerular filtration rate was higher in male current smokers. In addition, body weight was higher in female current smokers. In multivariable logistic regression analysis, smoking was significantly associated with the prevalence of dyslipidemia [P=6.3×10-10; odds ratio (OR), 1.81], hypertriglyceridemia (P=2.3×10-20; OR, 2.39), hypo-HDL-cholesterolemia (P=2.0×10-9; OR, 2.14), metabolic syndrome (P=0.0003; OR, 1.61) and chronic kidney disease (P=4.4×10-15; OR, 0.54) in men, but not in women. The results indicated that smoking is significantly associated with various metabolic abnormalities and prevalence of common diseases in Japanese individuals, with certain sex differences, which may lead to accelerated development of CVDs.

Entities:  

Keywords:  common disease; metabolic parameters; smoking

Year:  2017        PMID: 29109861      PMCID: PMC5663979          DOI: 10.3892/br.2017.991

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  54 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  The problem of tobacco smoking.

Authors:  Richard Edwards
Journal:  BMJ       Date:  2004-01-24

3.  Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

Authors:  W Y Craig; G E Palomaki; J E Haddow
Journal:  BMJ       Date:  1989-03-25

4.  Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people.

Authors:  Z A Solak; C Kabaroğlu; G Cok; Z Parildar; U Bayindir; D Ozmen; O Bayindir
Journal:  Clin Exp Med       Date:  2005-10       Impact factor: 3.984

Review 5.  Systemic effects of smoking.

Authors:  Dilyara G Yanbaeva; Mieke A Dentener; Eva C Creutzberg; Geertjan Wesseling; Emiel F M Wouters
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

6.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

7.  The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population.

Authors:  Hyung-Jin Yoon; Minseon Park; Hyeongseok Yoon; Ki-Young Son; Belong Cho; Suhnggwon Kim
Journal:  Hypertens Res       Date:  2009-01-30       Impact factor: 3.872

8.  Cigarette smoking and renovascular hypertension.

Authors:  J P Nicholson; S L Teichman; M H Alderman; T A Sos; T G Pickering; J H Laragh
Journal:  Lancet       Date:  1983-10-01       Impact factor: 79.321

9.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

10.  Association between smoking and blood pressure: evidence from the health survey for England.

Authors:  P Primatesta; E Falaschetti; S Gupta; M G Marmot; N R Poulter
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

View more
  4 in total

Review 1.  Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.

Authors:  Jacob C Hartz; Sarah de Ferranti; Samuel Gidding
Journal:  J Endocr Soc       Date:  2018-05-01

2.  Gender-biased kidney damage in mice following exposure to tobacco cigarette smoke: More protection in premenopausal females.

Authors:  Abdullah Kaplan; Emna Abidi; Nada J Habeichi; Rana Ghali; Hiam Alawasi; Christina Fakih; Kazem Zibara; Firas Kobeissy; Ahmad Husari; George W Booz; Fouad A Zouein
Journal:  Physiol Rep       Date:  2020-01

3.  The Accumulation of Key Stroke Risk Factors and Its Association With the Characteristics of Subjects: A Population Based Cross Sectional Study.

Authors:  Peng Zhang; Hang Jin; Zhen-Ni Guo; Hui-Jie Sun; Fu-Liang Zhang; Xin Sun; Yi Yang
Journal:  Front Neurol       Date:  2018-11-12       Impact factor: 4.003

4.  Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela.

Authors:  Valmore Bermudez; Luis Carlos Olivar; Wheeler Torres; Carla Navarro; Robys Gonzalez; Cristobal Espinoza; Alicia Morocho; Andres Mindiola; Maricarmen Chacin; Victor Arias; Roberto Añez; Juan Salazar; Manuel Riaño-Garzon; Edgar Diaz-Camargo; Maria Judith Bautista; Joselyn Rojas
Journal:  F1000Res       Date:  2018-05-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.